Cargando…
Sclerostin: From Molecule to Clinical Biomarker
Sclerostin, a glycoprotein encoded by the SOST gene, is mainly produced by mature osteocytes and is a critical regulator of bone formation through its inhibitory effect on Wnt signaling. Osteocytes are differentiated osteoblasts that form a vast and highly complex communication network and orchestra...
Autores principales: | Omran, Ahmed, Atanasova, Diana, Landgren, Filip, Magnusson, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104784/ https://www.ncbi.nlm.nih.gov/pubmed/35563144 http://dx.doi.org/10.3390/ijms23094751 |
Ejemplares similares
-
Sclerostin
por: Silverman, Stuart L.
Publicado: (2010) -
Sclerostin and Vascular Pathophysiology
por: Catalano, Antonino, et al.
Publicado: (2020) -
Sclerostin: clinical insights in muscle–bone crosstalk
por: Moretti, Antimo, et al.
Publicado: (2023) -
The Role of Sclerostin in Bone Diseases
por: Vasiliadis, Elias S., et al.
Publicado: (2022) -
Drug discovery of sclerostin inhibitors
por: Yu, Sifan, et al.
Publicado: (2022)